HIV Prevention with Pre-Exposure Prophylaxis (PrEP)
View the webinar on demand in MP4 format
(Pending review - CME not currently available)
This webinar has been approved for [ 1 ] AMA PRA Category 1 Credit™.
Original release date: November 7, 2016. Most recent review date: January 17, 2018. Termination date: November 7, 2019.
Continuing Medical Education Credit(s)
Physicians – to obtain a CME Certificate, view the webinar and click here (pending review - CME not currently available).
Other Health Care Providers – to obtain a Certificate of Attendance, view the webinar and click here (pending review - CME not currently available).
Antiretroviral drugs are an increasingly important component of HIV prevention, as they can reduce viral loads and infectiousness of persons living with HIV (i.e., “treatment as prevention”) and help prevent HIV acquisition in uninfected persons (i.e., “biomedical prevention”). Pre-exposure prophylaxis (PrEP) is one form of HIV biomedical prevention. Although PrEP has been shown to decrease risk of HIV by up to 99% when taken daily as prescribed, many medical providers are unaware that this prevention tool exists. The Centers for Disease Control and Prevention estimates that 1 in 3 primary care providers and nurses have never heard of PrEP. This webinar is designed to introduce providers to PrEP and provide them with the knowledge necessary to comfortably prescribe this prevention tool to their patients.
This activity is applicable for physicians in primary care and/or infectious disease specialists. Other groups who are encouraged to participate include nurses, epidemiologists, public health investigators, health educators, and community health workers.
At the conclusion of the lecture, participants will be able to:
- Conduct a Sexual History
- Discuss the LA County and CDC Guidelines for Pre-Exposure Prophylaxis (PrEP).
- Describe selection of candidates for PrEP.
- Discuss the management of the patient on PrEP.
- Discuss PrEP therapy and side effects.
- Discuss the challenges providers and patients face associated with PrEP.
- Discuss patient resources for PrEP education.
Leo Moore, MD, MSHPM
Dr. Leo Moore is the Acting Medical Director in the Division of HIV and STD Programs at the Los Angeles County Department of Public Health. In this role, he works to expand access to behavioral and biomedical HIV prevention tools for groups at highest risk of HIV acquisition. Dr. Moore also works closely with community stakeholders to develop innovative strategies to address STD rates in Los Angeles County. Dr. Moore regularly provides live continuing medical education regarding PrEP to community clinics and agencies in Los Angeles County and has been an active prescriber of PrEP since 2013.
Dr. Moore is a medical graduate of Morehouse School of Medicine, completed primary care internal medicine residency at Yale University School of Medicine, and recently completed his Masters of Science in Health Policy and Management at University of California, Los Angeles. He is the recipient of the 2015 "Top Healthcare Professionals under age 40" from the National Medical Association and the 2016 "Top 40 under 40 Leaders in Minority Health" from the National Minority Quality Forum/Congressional Black Caucus. In his spare time, Dr. Moore partners with the Male Success Alliance at California State University, Dominguez Hills to strengthen the pipeline to medical professions for young men of color.
Resources for Further Study
This webinar will refer to multiple documents, which can be accessed here:
- Click here for the Los Angeles County Department of Public Health PrEP Guidelines.
- Click here for the CDC’s PrEP Guidelines.
- Click here for a quick checklist to help you manage a patient on PrEP.
- Click here for the “Basics of PrEP”, a patient education resource.
The Los Angeles County Department of Public Health is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.
The Los Angeles County Department of Public Health designates this enduring activity for a maximum of [ 1 ] AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses receive a Certificate of attendance. This activity is designated for [ 1 ] AMA PRA Category 1 Credit(s)™. According to the California Board of Registered Nursing, the Continuing Medical Education is acceptable for meeting RN continuing education requirements, as long as the course is Category 1, and has been taken within the appropriate time frames.
The speaker, Dr. Leo Moore reports receiving financial remuneration from Gilead Sciences within the past year: he served on a Medical Affairs Community Advisory Board and provided unbranded presentations about HIV prevention. This presentation has been reviewed; there is no commercial bias, the best available evidence is used, and there is no mention of any specific brand-name agents.
No other planners involved in the planning or creation of this activity disclosed any relevant financial relationships
This activity is offered by an accredited CMA-CME provider and is not commercially supported.
For questions or further information, please contact: The Los Angeles County Department of Public Health, Division of HIV and STD Programs at (213) 351-8003.